Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 3/20 | 0.62 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.62 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.62 |
| ▸ | PNP | P00491 | 2/20 | 0.62 |
| ▸ | HINT1 | P49773 | 6/20 | 0.59 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.58 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.53 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.53 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | NT5E | P21589 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4414395 | 0.94 | GSK3A (0.60) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL8202770 | 0.94 | GSK3A (0.60) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL13597934 | 0.94 | GSK3A (0.60) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL16870493 | 0.91 | TAS1R3 (0.57) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL794488 | 0.90 | TAS1R3 (0.55) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL22337354 | 0.88 | HINT1 (0.56) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL26809512 | 0.88 | HINT1 (0.56) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL22337046 | 0.88 | HINT1 (0.56) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL5219707 | 0.88 | GSK3A (0.80) | GSK3ARPS6KA3MAPK14PNPHINT1 | |
| SCHEMBL13022843 | 0.86 | MEN1 (0.56) | GSK3ARPS6KA3MAPK14PNPHINT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171482-A1 | DEACYLATION OF CARBOHYDRATE COMPOUNDS | UNIVERSITY OF SOUTH ALABAMA | 2025-05-29 | — | — | US | disclosed |
| EP-2707483-B1 | METHODS AND MATERIALS FOR NUCLEIC ACID MANIPULATION | RWTH AACHEN UNIV (DE) | 2017-10-18 | — | — | EP | disclosed |
| US-20120295311-A1 | Methods and Materials for Nucleic Acid Manipulation | BASF SE (DE) | 2012-11-22 | — | — | US | disclosed |
| US-7268115-B2 | Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery | ADHEREX TECHNOLOGIES, INC. (CA) | 2007-09-11 | — | — | US | disclosed |
| US-20040241706-A1 | Highly specific modulators of GTPases for target validation | IRM, LLC | 2004-12-02 | — | — | US | disclosed |
| WO-2004024082-A2 | HIGHLY SPECIFIC MODULATORS OF GTPASES FOR TARGET VALIDATION | IRM, LLC (GB) | 2004-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040241706-A1 | Highly specific modulators of GTPases for target validation | CDC42, ARHGDIB, ARHGEF2 | GSK3A 4145/4885RPS6KA3 459/4885MAPK14 1487/4885 |
| US-20250171482-A1 | DEACYLATION OF CARBOHYDRATE COMPOUNDS | FUT5, DDOST, TREH | GSK3A 1444/4885RPS6KA3 2080/4885MAPK14 1743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.